Oceanía · Mercados regionales · Stockhead

Recce topical gel shows strong diabetic foot infection efficacy ahead of Phase III data review

Publicado por Stockhead · Australia hace 7 h

A review of blinded data from Recce’s Phase III trial of its RECCE 327 Gel in diabetic foot infections has ... Read More The post Recce topical gel shows strong diabetic foot…

Leer el artículo completo en Stockhead Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (stockhead.com.au)

Recce topical gel shows strong diabetic foot infection efficacy ahead of Phase III data review

También te puede interesar

Landholders and politicians push for tougher laws on renewable energy developments

FROM THE HILL: A snapshot of today's politics and parliament

Here are the top 10 ASX 200 shares today

Bellroy reveals plans for 20 stores as Australian accessories brand goes global with physical retail

Welcome to peak chaos

Escrow plans for existing investors sank Firmus float: report

Recce topical gel shows strong diabetic foot infection efficacy ahead of Phase III data review

Compartir

También te puede interesar

Landholders and politicians push for tougher laws on renewable energy developments

FROM THE HILL: A snapshot of today's politics and parliament

Here are the top 10 ASX 200 shares today

Bellroy reveals plans for 20 stores as Australian accessories brand goes global with physical retail

Welcome to peak chaos

Escrow plans for existing investors sank Firmus float: report